Chimeric Therapeutics Ltd (ASX:CHM) Share Price and News

Market Cap (19-Sep) $4,960,185 (1,007th)	Close (30-Jun) $0.038 0 (0%)	Volume (30-Jun) 1,963,571	Shortsold (11-May) 1 (0.00%) (717th)
52w High $0.60	52w Low $0.083	P/E -	EPS -0.84

	Subject
	CHM CHM Ann: Notice under section 708A
	1 (current) 2 3
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Results of Extraordinary General Meeting
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Proposed issue of securities - CHM
	CHM CHM Ann: Proposed issue of securities - CHM
	CHM CHM Ann: CHM secures up to A$12.6m through SPP and placements
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Share purchase plan completed
	CHM CHM Ann: Chimeric's Phase 1B glioblastoma trial presented at ASCO23
	CHM CHM Ann: Launch of new Phase 1B Glioblastoma clinical trial
	CHM CHM Ann: Update - Proposed issue of securities - CHM
	CHM CHM Ann: Share purchase plan (SPP) - closing date extended
	CHM CHM Ann: Notice of Extraordinary General Meeting/Proxy Form
	CHM CHM Ann: SPP offer documents issued to shareholders
	CHM CHM Ann: SPP Cleansing Notice
	CHM CHM Ann: Proposed issue of securities - CHM
	CHM CHM Ann: Proposed issue of securities - CHM
	CHM CHM Ann: BOARD & MANAGEMENT COMMIT TO $1M PLACEMENT AND PROPOSED SPP
	CHM CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CHM CHM Ann: New CLTX CAR technology patent protection in India & Israel
	CHM CHM Ann: Phase 1B brain cancer clinical trial approved for initiation
	CHM CHM Ann: CHM to host CAR T Cell Therapies Educational Webinar
	CHM CHM Ann: CHM 1101 GBM Abstract Accepted for ASCO 2023 Presentation
	CHM CHM Ann: Positive pre-IND meeting with FDA for Phase 1 CAR T study
	CHM CHM Ann: Chimeric to present at virtual healthcare conference
	CHM CHM Ann: Completion of Viral Vector Manufacturing for Phase 1 trial
	CHM CHM Ann: Fourth dose cohort initiated in CHM 1101 Phase 1 trial
	CHM CHM Ann: Appendix 4D and Half Year Report
	CHM CHM Ann: CHIMERIC RECEIVES $3.06M R&D TAX INCENTIVE
	CHM CHM Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CHM CHM Ann: Follow up period completed for 3rd cohort in CHM 1101 trial
	CHM CHM Ann: 1st patient dosed in CHM 0201 Vactosertib trial
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Release of Securities from Escrow
	CHM CHM Ann: Notice under section 708A
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Dosing complete in 3rd cohort of CHM 1101 (CLTX CAR T) trial
	CHM CHM Ann: Change of Director's Interest Notice - JC
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Change of Director's Interest Notice - JC
	CHM CHM Ann: License agreement with CWRU - supplementary announcement
	CHM CHM Ann: Exclusive license agreement with CWRU for CORE-NK platform
	CHM CHM Ann: Notification regarding unquoted securities - CHM
	CHM CHM Ann: Notice under section 708A
	CHM CHM Ann: Application for quotation of securities - CHM
	CHM CHM Ann: Results of Meeting
	CHM CHM Ann: AGM Presentation
	CHM CHM Ann: AGM ATTENDANCE
	CHM CHM Ann: Sponsored Research Agreement to advance CORE-NK portfolio

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	3,199,999	+0.00 (33.33%)
12-Sep	$0.00	1,621,588	0.00 (0.00%)
11-Sep	$0.00	4,147,698	0.00 (0.00%)
05-Sep	$0.00	33,560,043	+0.00 (50.00%)
04-Sep	$0.00	14,909,951	0.00 (33.33%)
03-Sep	$0.00	2,714,060	0.00 (0.00%)
29-Aug	$0.00	12,601,385	0.00 (0.00%)
28-Aug	$0.00	31,406,613	0.00 (0.00%)
22-Aug	$0.00	9,836	0.00 (0.00%)
21-Aug	$0.00	1,597,558	0.00 (0.00%)
15-Aug	$0.00	17,970,592	0.00 (14.29%)
14-Aug	$0.00	165,625	+0.00 (16.67%)
07-Aug	$0.00	4,812,305	0.00 (0.00%)
31-Jul	$0.00	3,775,000	0.00 (25.00%)
30-Jul	$0.00	312,291	+0.00 (33.33%)
4 up, 3 down, and 8 flat days

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

Chimeric Therapeutics Ltd Health Care

$0.038 0.001 (2.70%)

$0.038 0.001 (2.70%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices